Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 14 de 14
Filter
1.
BMC Complement Altern Med ; 18(1): 254, 2018 Sep 17.
Article in English | MEDLINE | ID: mdl-30223811

ABSTRACT

BACKGROUND: Pancreatic cancer is one of the most aggressive and mortal cancers. Although several drugs have been proposed for its treatment, it remains resistant and new alternatives are needed. In this context, plants and their derivatives constitute a relevant source of bioactive components which might efficiently inhibit tumor cell progression. METHODS: In this study, we have analyzed the potential anti-carcinogenic effect of different Asteraceae (Achillea millefolium and Calendula officinalis) and Lamiaceae (Melissa officinalis and Origanum majorana) plant extracts obtained by different green technologies (Supercritical CO2 Extraction -SFE- and Ultrasonic Assisted Extraction -UAE-) to identify efficient plant extracts against human pancreatic cancer cells that could constitute the basis of novel treatment approaches. RESULTS: Asteraceae extracts showed better results as antitumoral agents than Lamiaceae by inducing cytotoxicity and inhibiting cell transformation, and SFE extracts were most efficient than UAE extracts. In addition, SFE derived plant extracts from Achillea millefolium and Calendula officinalis displayed synergism with the chemotherapeutic 5-Fluororacil. CONCLUSION: These results show how Yarrow and Marigold SFE-derived extracts can inhibit pancreatic cancer cell growth, and could be proposed for a comprehensive study to determine the molecular mechanisms involved in their bioactivity with the final aim to propose them as potential adjuvants in pancreatic cancer therapy.


Subject(s)
Antineoplastic Agents/pharmacology , Asteraceae/chemistry , Lamiaceae/chemistry , Pancreatic Neoplasms/metabolism , Plant Extracts/pharmacology , Antineoplastic Agents/chemistry , Caspases/metabolism , Cell Line, Tumor , Cell Survival/drug effects , Fluorouracil , Humans , Plant Extracts/chemistry
8.
Med Clin (Barc) ; 130(8): 292-4, 2008 Mar 08.
Article in Spanish | MEDLINE | ID: mdl-18358120

ABSTRACT

BACKGROUND AND OBJECTIVE: The aim of this study was to describe the evolution of serologically confirmed cases of mumps in the Madrid Community from 2000 to 2006. PATIENTS AND METHOD: Cases with data about age, sex and with samples obtained < or = 30 days after the onset of symptoms were included. IgM determination was performed by indirect ELISA (Enzygnost Mumps; Dade Behring). IgM positive cases were considered as confirmed. RESULTS: Information was available from 1,173 cases. Two hundred and fifty two of them (21.5%) were confirmed. The percentage of confirmed cases by year ranged between 21.4% and 27.2% (except for 2003 [10.7%], and 2004 [2.1%]). In the first years most confirmed cases corresponded to children (85.7% in 2000 and 68.6% in 2001) while in last years it was the opposite (10.7% in 2005 and 23.4% en 2006). CONCLUSIONS: These results indicate the appearance of 2 epidemic waves (in 2000--2002 and in 2005--2006). Currently, mumps should not be considered an exclusively pediatric disease.


Subject(s)
Mumps/epidemiology , Adolescent , Adult , Age Factors , Antibodies, Viral/blood , Child , Enzyme-Linked Immunosorbent Assay , Female , Humans , Immunoglobulin M/blood , Male , Mumps/immunology , Mumps/prevention & control , Mumps Vaccine/administration & dosage , Mumps virus/immunology , Sex Factors , Spain/epidemiology
9.
Med. clín (Ed. impr.) ; 130(8): 292-294, mar. 2008. tab
Article in Es | IBECS | ID: ibc-63536

ABSTRACT

Fundamento y objetivo: El objetivo de este estudio es describir la evolución de los casos de parotiditis confirmados serológicamente en la Comunidad de Madrid durante 2000-2006. Pacientes y método: Se seleccionaron los casos con datos de edad, sexo y cuyas muestras se extrajeron antes de 30 días desde el inicio de los síntomas. La determinación de la inmunoglobulina (Ig) M se realizó mediante enzimoinmunoanálisis indirecto (Enzygnost Parotiditis; Dade Behring). Se consideraron casos confirmados aquellos con IgM específica positiva. Resultados: Se dispuso de información de 1.173 casos y se confirmaron 252 (21,5%). El porcentaje de casos confirmados por año osciló entre el 21,4 y el 27,2% (excepto en 2003, que fue del 10,7%, y en 2004, que fue del 2,1%). En los primeros años, la mayoría de los casos confirmados correspondieron a niños (el 85,7% en 2000 y el 68,6% en 2001), mientras que en los últimos sucedió a la inversa (el 10,7% en 2005 y el 23,4% en 2006). Conclusiones: Estos resultados indican la aparición de 2 ondas epidémicas (en 2000-2002 y en 2005-2006). En la actualidad no debe considerarse la parotiditis como una enfermedad exclusivamente pediátrica


Background and objective: The aim of this study was to describe the evolution of serologically confirmed cases of mumps in the Madrid Community from 2000 to 2006. Patients and method: Cases with data about age, sex and with samples obtained # 30 days after the onset of symptoms were included. IgM determination was performed by indirect ELISA (Enzygnost Mumps; Dade Behring). IgM positive cases were considered as confirmed. Results: Information was available from 1,173 cases. Two hundred and fifty two of them (21.5%) were confirmed. The percentage of confirmed cases by year ranged between 21.4% and 27.2% (except for 2003 [10.7%], and 2004 [2.1%]). In the first years most confirmed cases corresponded to children (85.7% in 2000 and 68.6% in 2001) while in last years it was the opposite (10.7% in 2005 and 23.4% en 2006). Conclusions: These results indicate the appearance of 2 epidemic waves (in 2000-2002 and in 2005-2006). Currently, mumps should not be considered an exclusively pediatric disease


Subject(s)
Humans , Male , Female , Child , Adult , Parotitis/epidemiology , Mumps virus/pathogenicity , Serologic Tests , Immunoglobulin G/analysis , Immunoenzyme Techniques , Mumps Vaccine
10.
Enferm Infecc Microbiol Clin ; 24(9): 564-7, 2006 Nov.
Article in Spanish | MEDLINE | ID: mdl-17125676

ABSTRACT

INTRODUCTION: The aim of this study was to assess two ELISA techniques for the detection of outbreaks of norovirus. METHOD: One-hundred and sixty-five fecal samples from patients affected in 30 outbreaks were studied. RESULTS: On the basis of a specific consensus criterion between techniques for confirming outbreaks, the sensitivity and specificity was respectively 80% and 90% for RIDASCREEN, and 80% and 100% for IDEIA. CONCLUSION: These techniques could be useful for rapid detection of norovirus outbreaks in laboratories that lack molecular confirmation techniques.


Subject(s)
Caliciviridae Infections/virology , Enzyme-Linked Immunosorbent Assay/methods , Feces/virology , Gastroenteritis/virology , Adult , Aged , Aged, 80 and over , Caliciviridae Infections/diagnosis , Caliciviridae Infections/epidemiology , Child , Child Day Care Centers , Child, Preschool , Disease Outbreaks , Gastroenteritis/diagnosis , Gastroenteritis/epidemiology , Hospitalization , Humans , Norovirus , Nursing Homes , Reproducibility of Results , Restaurants , Schools , Sensitivity and Specificity , Spain/epidemiology
11.
APMIS ; 114(11): 788-94, 2006 Nov.
Article in English | MEDLINE | ID: mdl-17078860

ABSTRACT

The aim of the study was to evaluate the usefulness of serological detection of mumps IgM and titration of IgG in patients with acute parotitis according to their vaccination status. The detection of mumps virus RNA in saliva by RT-PCR was used as reference. 116 patients (109 of them previously vaccinated) with mumps RT-PCR-negative results and 21 (19 vaccinated) with mumps RT-PCR-positive results were studied. Mumps-specific IgM and IgG were assayed by EIA (Enzygnost, Dade Behring, Germany). IgM results were expressed as positive or negative. For IgG, several cut-offs were calculated using receiver operating characteristic (ROC) curves. Seven RT-PCR-positive and five RT-PCR-negative patients showed IgM-positive results (sensitivity 33.3% and specificity 95.7%). Among vaccinated patients, the sensitivity and specificity of IgM were 26.3% (5/19) and 99.1% (108/109). For IgG, a titer of 5,000 in all the patients showed a sensitivity of 76.2% (16/21) and a specificity of 83.6% (97/116). In vaccinated patients, the corresponding figures for this cut-off were 84.2% (16/19) and 83.5% (91/109), respectively. Although IgM detection against mumps is highly specific, its sensitivity is very low in immunized subjects. In this group, the titration of IgG could serve as an additional diagnostic tool.


Subject(s)
Antibodies, Viral/blood , Immunoenzyme Techniques , Immunoglobulin G/blood , Mumps virus/isolation & purification , Mumps/diagnosis , DNA, Viral/analysis , Humans , Immunoglobulin M/blood , Mumps/prevention & control , Reverse Transcriptase Polymerase Chain Reaction , Sensitivity and Specificity , Sputum/virology , Vaccination
12.
Enferm. infecc. microbiol. clín. (Ed. impr.) ; 24(9): 564-567, nov. 2006. tab
Article in Es | IBECS | ID: ibc-051043

ABSTRACT

Introducción. El objetivo de este estudio fue evaluar dos ELISA para la detección de brotes por norovirus. Método. Se estudiaron 165 muestras de heces de pacientes afectados en 30 brotes. Resultados. Considerando un criterio específico de consenso entre técnicas para la confirmación de brotes, la sensibilidad y especificidad fue para RIDASCREEN del 80 y 90% y para IDEIA del 80 y de 100%. Conclusión. Estas técnicas quizá podrían resultar útiles para la detección de brotes por norovirus en laboratorios que carezcan de técnicas moleculares (AU)


Introduction. The aim of this study was to assess two ELISA techniques for the detection of outbreaks of norovirus. Method. One-hundred and sixty-five fecal samples from patients affected in 30 outbreaks were studied. Results. On the basis of a specific consensus criterion between techniques for confirming outbreaks, the sensitivity and specificity was respectively 80% and 90% for RIDASCREEN, and 80% and 100% for IDEIA. Conclusion. These techniques could be useful for rapid detection of norovirus outbreaks in laboratories that lack molecular confirmation techniques (AU)


Subject(s)
Humans , Norovirus/isolation & purification , Enzyme-Linked Immunosorbent Assay/methods , Caliciviridae Infections/diagnosis , Disease Outbreaks , Gastroenteritis/epidemiology
13.
Enferm Infecc Microbiol Clin ; 24(4): 251-3, 2006 Apr.
Article in Spanish | MEDLINE | ID: mdl-16725085

ABSTRACT

Nowadays, most exanthematic diseases for which a vaccine is available affect young adults. A large percentage of these cases prove to be rubella. The aim of this study is to assess the performance of specific IgM and RT-PCR for the diagnosis of rubella infection. Fifty-nine patients with clinically suspected measles or rubella, and with available serum, whole blood, urine and pharyngeal exudate specimens were studied. RT-PCR in pharyngeal exudate was found to be the most effective marker at the start of the disease (mean, 2.5 days). IgM detection yielded a larger percentage of positive results (76.2%), but at a later time (3.7 days).


Subject(s)
Antibodies, Viral/blood , Gene Amplification , Immunoglobulin M/blood , Reverse Transcriptase Polymerase Chain Reaction , Rubella/diagnosis , Adolescent , Adult , Child , Child, Preschool , Female , Humans , Male , Middle Aged , Pharynx/virology , Predictive Value of Tests , Prospective Studies , RNA, Viral/blood , Rubella/blood , Rubella/urine , Rubella/virology , Rubella virus/immunology
14.
Enferm. infecc. microbiol. clín. (Ed. impr.) ; 24(4): 251-253, abr. 2006. tab
Article in Es | IBECS | ID: ibc-047905

ABSTRACT

En la actualidad la mayoría de los casos de enfermedades exantemáticas prevenibles por inmunización afectan a jóvenes. Además, una elevada proporción de estos casos se confirman como rubéola. El objetivo de este estudio es evaluar el rendimiento de la IgM específica y una técnica de reacción en cadena de la polimerasa en tiempo real (RT-PCR) en el diagnóstico de la infección por virus de la rubéola. Se estudiaron 59 pacientes bajo sospecha clínica de sarampión o rubéola de los cuales se disponía de muestras de suero, sangre completa, orina y exudado faríngeo. Se comprobó que la RT-PCR en exudado faríngeo fue el marcador diagnóstico más eficaz en los primeros días de la enfermedad (2,5 días de media). Sin embargo, la detección de IgM mostró un mayor rendimiento (76,2%), aunque más tardíamente (3,7 días) (AU)


Nowadays, most exanthematic diseases for which a vaccine is available affect young adults. A large percentage of these cases prove to be rubella. The aim of this study is to assess the performance of specific IgM and RT-PCR for the diagnosis of rubella infection. Fifty-nine patients with clinically suspected measles or rubella, and with available serum, whole blood, urine and pharyngeal exudate specimens were studied. RT-PCR in pharyngeal exudate was found to be the most effective marker at the start of the disease (mean, 2.5 days). IgM detection yielded a larger percentage of positive results (76.2%), but at a later time (3.7 days) (AU)


Subject(s)
Child , Adult , Child, Preschool , Adolescent , Middle Aged , Humans , Antibodies, Viral/blood , Gene Amplification , Immunoglobulin M/blood , Reverse Transcriptase Polymerase Chain Reaction , Rubella/diagnosis , Pharynx/virology , RNA, Viral/blood , Rubella/blood , Rubella/urine , Rubella/virology , Rubella virus/immunology , Predictive Value of Tests
SELECTION OF CITATIONS
SEARCH DETAIL
...